These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 34864002)

  • 1. The role of mitochondria in the pathophysiology of schizophrenia: A critical review of the evidence focusing on mitochondrial complex one.
    Whitehurst T; Howes O
    Neurosci Biobehav Rev; 2022 Jan; 132():449-464. PubMed ID: 34864002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine.
    Ben-Shachar D
    J Neurochem; 2002 Dec; 83(6):1241-51. PubMed ID: 12472879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia.
    Maurer I; Zierz S; Möller H
    Schizophr Res; 2001 Mar; 48(1):125-36. PubMed ID: 11278159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial multifaceted dysfunction in schizophrenia; complex I as a possible pathological target.
    Ben-Shachar D
    Schizophr Res; 2017 Sep; 187():3-10. PubMed ID: 27802911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cognition, schizophrenia and the effect of antipsychotics].
    Stip E
    Encephale; 2006; 32(3 Pt 1):341-50. PubMed ID: 16840928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder.
    Andreazza AC; Shao L; Wang JF; Young LT
    Arch Gen Psychiatry; 2010 Apr; 67(4):360-8. PubMed ID: 20368511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translating preclinical findings in clinically relevant new antipsychotic targets: focus on the glutamatergic postsynaptic density. Implications for treatment resistant schizophrenia.
    de Bartolomeis A; Avagliano C; Vellucci L; D'Ambrosio L; Manchia M; D'Urso G; Buonaguro EF; Iasevoli F
    Neurosci Biobehav Rev; 2019 Dec; 107():795-827. PubMed ID: 31461641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioenergetic flux, mitochondrial mass and mitochondrial morphology dynamics in AD and MCI cybrid cell lines.
    Silva DF; Selfridge JE; Lu J; E L; Roy N; Hutfles L; Burns JM; Michaelis EK; Yan S; Cardoso SM; Swerdlow RH
    Hum Mol Genet; 2013 Oct; 22(19):3931-46. PubMed ID: 23740939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia.
    Clay HB; Sillivan S; Konradi C
    Int J Dev Neurosci; 2011 May; 29(3):311-24. PubMed ID: 20833242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative proteomics analysis of rat mitochondria from the cerebral cortex and hippocampus in response to antipsychotic medications.
    Ji B; La Y; Gao L; Zhu H; Tian N; Zhang M; Yang Y; Zhao X; Tang R; Ma G; Zhou J; Meng J; Ma J; Zhang Z; Li H; Feng G; Wang Y; He L; Wan C
    J Proteome Res; 2009 Jul; 8(7):3633-41. PubMed ID: 19441803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial dysfunction in schizophrenia: With a focus on postmortem studies.
    Roberts RC
    Mitochondrion; 2021 Jan; 56():91-101. PubMed ID: 33221354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia.
    Goff DC; Coyle JT
    Am J Psychiatry; 2001 Sep; 158(9):1367-77. PubMed ID: 11532718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress-mediated activation of extracellular signal-regulated kinase contributes to mild cognitive impairment-related mitochondrial dysfunction.
    Gan X; Wu L; Huang S; Zhong C; Shi H; Li G; Yu H; Howard Swerdlow R; Xi Chen J; Yan SS
    Free Radic Biol Med; 2014 Oct; 75():230-40. PubMed ID: 25064321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The microvascular alterations in frontal cortex during treatment with antipsychotics: a post-mortem study.
    Udriştoiu I; Marinescu I; Pîrlog MC; Militaru F; Udriştoiu T; Marinescu D; Mutică M
    Rom J Morphol Embryol; 2016; 57(2):501-6. PubMed ID: 27516025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schizophrenia Synaptic Pathology and Antipsychotic Treatment in the Framework of Oxidative and Mitochondrial Dysfunction: Translational Highlights for the Clinics and Treatment.
    De Simone G; Mazza B; Vellucci L; Barone A; Ciccarelli M; de Bartolomeis A
    Antioxidants (Basel); 2023 Apr; 12(4):. PubMed ID: 37107350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine attenuates mitochondrial dysfunction, inflammatory gene expression, and behavioral abnormalities in an animal model of schizophrenia.
    Amiri S; Dizaji R; Momeny M; Gauvin E; Hosseini MJ
    Neuropharmacology; 2021 Apr; 187():108503. PubMed ID: 33636190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmortem studies on mitochondria in schizophrenia.
    Roberts RC
    Schizophr Res; 2017 Sep; 187():17-25. PubMed ID: 28189530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis- and Cell Type-Specific Mitochondrial Functional Pathway Signatures in Schizophrenia and Bipolar Disorder.
    Glausier JR; Enwright JF; Lewis DA
    Am J Psychiatry; 2020 Dec; 177(12):1140-1150. PubMed ID: 33115248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial activity and oxidative stress markers in peripheral blood mononuclear cells of patients with bipolar disorder, schizophrenia, and healthy subjects.
    Gubert C; Stertz L; Pfaffenseller B; Panizzutti BS; Rezin GT; Massuda R; Streck EL; Gama CS; Kapczinski F; Kunz M
    J Psychiatr Res; 2013 Oct; 47(10):1396-402. PubMed ID: 23870796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.